Skip to main content

Plantar soft tissues and Achilles tendon thickness and stiffness in people with diabetes: a systematic review



Diabetes mellitus is associated with changes in soft tissue structure and function. However, the directionality of this change and the extent to which either tissue thickness or stiffness contributes to the pathogenesis of diabetes-related foot ulcerations is unclear. Hence, this systematic review aims to summarise the existing evidence for soft tissue structural differences in the feet of people with and without diabetes.


In compliance with MOOSE and PRISMA guidelines, AMED, CINAHL, MEDLINE, ProQuest Health & Medical Collection, ProQuest Nursing & Allied Health Database, and Web of Science electronic databases were systematically searched for studies published from database inception until 1st October 2020 [Prospero CRD42020166614]. Reference lists of included studies were further screened. Methodological quality was appraised using a modified critical appraisal tool for quantitative studies developed by McMaster University.


A total of 35 non-randomised observational studies were suitable for inclusion. Within these, 20 studies evaluated plantar tissue thickness, 19 studies evaluated plantar tissue stiffness, 9 studies evaluated Achilles tendon thickness and 5 studies evaluated Achilles tendon stiffness outcomes. No significant differences in plantar tissue thickness were found between people with and without diabetes in 55% of studies (11/20), while significantly increased plantar tissue stiffness was found in people with diabetes in 47% of studies (9/19). Significantly increased Achilles tendon thickness was found in people with diabetes in 44% of studies (4/9), while no significant differences in Achilles tendon stiffness were found between people with and without diabetes in 60% of studies (3/5).


This systematic review found some evidence of soft tissue structural differences between people with and without diabetes. However, uncertainty remains whether these differences independently contribute to diabetes-related foot ulcerations. The heterogeneity of methodological approaches made it difficult to compare across studies and methodological quality was generally inadequate. High-quality studies using standardised and validated assessment techniques in well-defined populations are required to determine more fully the role of structural tissue properties in the pathogenesis of diabetes-related foot ulcerations.

Peer Review reports


Diabetes-related foot ulcerations (DFUs) are one of the most challenging complications of diabetes mellitus. They are associated with high morbidity and mortality [1, 2], with non-healing DFUs preceding up to 85% of all non-traumatic lower limb amputations [3], and are costly to healthcare systems [4]. Factors associated with the pathogenesis of DFUs are complex and multifactorial, but fundamentally involve the interaction of extrinsic biomechanical forces with intrinsic structural and functional properties of the skin and underlying soft tissues [5, 6].

Histological changes have been observed in the plantar soft tissues [7, 8] and Achilles tendon (AT) [9, 10] in diabetes. Non-enzymatic glycosylation following persistent hyperglycaemia, a key characteristic of diabetes, results in an excessive accumulation of advanced glycosylation end-products (AGEs) in most human organs and tissues [11]. This includes, but is not limited to, muscles, nerves, skin and tendons [12, 13]. Concomitant remodelling in the structural composition of the affected tissue [14] could alter mechanical behaviour, and in the presence of other established risk factors such as diabetes-related peripheral neuropathy (DPN) and foot deformity [4], may increase the risk of DFU development.

Increased tissue stiffness [15], particularly in the AT [16], and decreased tissue thickness are perceived to be independent risk factors for DFU. Increased plantar tissue stiffness (PTS) is thought to alter the distribution of tensile stresses in the plantar soft tissues during gait [15]. Consequently, repetitive biomechanical stresses normally sustained by the foot through activities of daily living may no longer be as effectively dissipated. Combined with a reduction in plantar tissue thickness (PTT), these changes could collectively decrease the mechanical loads required to initiate soft tissue breakdown and thus lead to DFU formation.

As a separate entity, increased Achilles tendon stiffness (ATS) reduces ankle joint motion and is associated with increased forefoot plantar pressures [16]. The AT is a compliant tendon, and its ability to stretch and recoil as it produces propulsion and absorbs ground reaction forces is integral to locomotion [17]. Increased ATS could negatively affect its dynamic potential and ankle joint range of motion [18]. Such changes may not only increase the AT’s susceptibility to mechanical fatigue [19], and thus predisposition to Achilles tendinopathy [20], but it could also lead to the abnormal distributions of forces across the plantar surface of the foot during weightbearing activities. Should these forces be concentrated over a focal area, plantar pressures could potentially increase beyond the withstanding capacity of affected plantar tissues.

Altogether, these changes bear the potential to reduce shock-absorbing capacity of the plantar tissues thus lowering the threshold for which integrity of the skin is breached, while at the same time magnify biomechanical stresses at localised sites, thereby considerably increasing the individual’s propensity to ulceration. However, the extent to which tissue thickness and stiffness contributes to DFU pathogenesis is unclear. Ulcerations and their recurrence are frequent sequelae [6, 21], yet prospective studies investigating changes to plantar tissue structure and function appear scarce. Therefore, the aim of this systematic review was to evaluate the evidence for changes to soft tissue thickness and stiffness at the plantar tissues and AT in people with diabetes.


This systematic review was conducted in compliance with the Meta-analyses Of Observational Studies in Epidemiology (MOOSE) [22] and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) [23] guidelines. The protocol was prospectively registered on Prospero [CRD42020166614].

Search strategy

Six electronic databases were systematically searched by the first reviewer (B.K.) for studies published from database inception until 1st October 2020. The databases were: EBSCOhost (AMED, CINAHL, MEDLINE), ProQuest (Health & Medical Collection, Nursing & Allied Health Database), and Web of Science. No date restrictions were imposed, however, studies were restricted to those published in English and in peer-reviewed journals only. Boolean operators and relevant MeSH terms were used and keywords were adapted for each database (Additional file 1).

Inclusion and exclusion criteria

Studies which met criteria in the following five categories were eligible for inclusion. (1) Population: cohorts comprised of adults 18 years old and above were included; experiments conducted on animals, artificial tissues, cadavers or minors below 18 years old were excluded. (2) Interventions: no restrictions set. (3) Comparison: studies which had made a comparison between cohorts with and without diabetes were included; non-comparative studies, specifically studies which had not included a control group of otherwise healthy adults, were excluded. (4) Outcomes: in-vivo assessments of either thickness and/or stiffness of plantar soft tissues and/or the AT were included; in-vitro studies, studies which assessed other body parts or internal body organs, or technical studies solely evaluating the physics or engineering of the measurement technique were excluded. (5) Type of study: quantitative primary research studies published in peer-reviewed journals were included; qualitative studies, case reports, commentaries, conference proceedings, narrative reviews, and studies published in non-peer reviewed journals were excluded.

Study selection

All articles retrieved in the search were first exported to RefWorks for removal of duplicates and subsequently exported to Covidence. Two reviewers (B.K. and R.B.) independently screened all titles and abstracts against pre-established inclusion and exclusion criteria. Articles which appeared to be eligible were retrieved in full and assessed by both reviewers. Upon mutual agreement for inclusion, the reference lists of included articles were additionally screened. This iterative process was performed until no further articles could be included. Where full-text articles could not be accessed, university library services were employed and authors contacted directly; this was successful on six occasions. Throughout this process, discrepancies were first resolved by consensus between the two reviewers (B.K. and R.B.) with adjudications sought from a third reviewer (J.W.) where required.

Methodological quality assessment

All included studies were appraised for their methodological quality using a modified critical appraisal tool for quantitative studies developed by McMaster University [24]. This modified tool comprehensively evaluates 14 different aspects of methodological quality, categorised under the domains: study purpose, literature, design, sample, outcome, assessment technique, results, conclusions and implications. Quality assessment was performed by the first reviewer (B.K.) and checked in full by the second reviewer (R.B.). As the thresholds for distinguishing between study quality grades have not been established, study quality was scored upon mutual agreement by two reviewers (B.K. and R.B.). Assessment rubrics [25] provided by McMaster University to guide the completion and interpretation of each criterion were adhered to, and where additional criteria were applied by the reviewers, these are detailed as follows.

Criteria for assessing sample

The sample description was deemed as limited if participant inclusion or exclusion criteria, and/or baseline characteristics of body mass index (BMI), duration of diabetes or HbA1c levels of the cohort were not reported. This lack of detail limits the reviewers’ attempts to establish comparability of diabetes, DPN and DFU cohorts within studies. Potential confounders were identified a priori as age, sex and BMI due to their known effects on soft tissue thickness [26,27,28] and stiffness [29,30,31,32]. Where groups were matched for all three baseline demographics, studies were deemed to have adopted strategies to reduce confounding. Where studies matched for only one or two of the aforementioned baseline demographics or any other potential confounders, the confounding strategy was deemed as limited.

Criteria for assessing reliability or validity of outcome measures

Studies which had either tested for or cited previous works demonstrating the reliability or validity of their chosen assessment tool for the relevant outcome measures were recognised to have addressed these domains. Where reliability or validity was addressed for other assessment techniques within the study, but not those relating to PTT, PTS, Achilles tendon thickness (ATT) or ATS outcomes, or was not mentioned at all, the study was deemed to not have addressed this domain.

Data extraction

Data extraction was performed independently by the first reviewer (B.K.) and checked for accuracy by the second reviewer (R.B.). A pre-specified data extraction sheet was used to extract data from all studies, which includes: (1) Article information: title, authors and year of publication; (2) Methods: study design, setting, participant demographics, participant inclusion and exclusion criteria, type of assessment tool utilised, outcome metric, and method of measurement for thickness or stiffness; and (3) Main findings. Within studies, statistical significance was defined as p < 0.05.

Data synthesis

A descriptive synthesis was conducted using summary data from individual studies to identify the directionality of PTT, PTS, ATT and ATS changes in people with diabetes when compared to their controls. Absolute values for PTT and ATT were further extracted. Where sufficient data permits, subgroup analysis was undertaken to identify the presence of any anatomical variations across the plantar aspect of the foot and the length of the AT, and to explore how findings may compare across cohorts with different diabetes-related complications. This includes people with DPN or people with either an active or history of DFUs.


The search strategy yielded a total of 668 articles, from which 68 full-text articles were screened (Fig. 1). 33 articles were excluded and the reasons for exclusion can be found in Additional file 2. A total of 35 studies were included in the analysis, giving a pooled diabetes sample of 1379 and 861 controls (Table 1). 21 studies [33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53] (60%) included people with Type 2 diabetes only, which is recognised to account for approximately 90–95% of diagnosed cases of diabetes worldwide [54].

Fig. 1

PRISMA diagram

Table 1 Overview of studies

Studies were published across three decades (1985 to 2020), with sample sizes ranging from 8 to 190 participants. The mean age of participants with diabetes was 58.5 years and their mean BMI was 27.3. The mean age of controls was 51.6 years and their mean BMI was 26.0. Participant comparison groups included healthy controls, people with diabetes but without DPN, people with DPN, and people with either an active or history of DFUs.

From 35 included studies, 20 studies evaluated PTT outcomes [36, 37, 39,40,41,42,43, 45, 46, 49, 50, 52, 53, 55,56,57,58,59,60,61], 19 studies evaluated PTS outcomes [34, 36, 40,41,42, 44,45,46, 50,51,52,53, 55, 56, 58, 59, 62,63,64], 9 studies evaluated ATT outcomes [33, 35, 38, 41, 47, 48, 65,66,67] and 5 studies evaluated ATS outcomes [33, 35, 38, 41, 68]. Heterogeneity among methods of measuring thickness and stiffness outcome metrics was observed which prohibited direct comparison across studies and precludes the possibility of conducting a meta-analysis.

Methodological quality assessment

All 35 papers included were non-randomised observational studies assessed to be of low quality. Overall, the degree of reporting was deemed to be inadequate for the following components of methodological quality: study design, sample size justifications, strategies to reduce confounding, reliability and validity of outcome measures utilised, and assessment techniques (Table 2).

Table 2 Methodological quality appraisal

Study purpose, literature and design

The purpose of the study and supporting background literature was generally well reported. Even though study designs were explicitly stated in only 43% of studies (15/35), the designs were considered appropriate.


Consecutive [47, 65] or convenience [41, 43, 45, 55] sampling was reported in 17% of studies (6/35); the remaining 83% of studies (29/35) made no mention of their sampling method. Sample size was justified with power calculations in only one study (3%) [68]. The difference between groups with diabetes and control groups in age, sex and BMI was statistically not significant in 40% of studies (14/35) [35, 37, 38, 44, 46, 47, 49, 53, 56, 57, 63, 64, 66, 67].

Reliability and validity of outcome measures

Reliability of outcomes measures was reported in 40% of studies (14/35). For PTT, reliability was reported for computed tomography (CT) [57], magnetic resonance imaging (MRI) [37], ultrasonography (US) probe with dynamometer [40], tissue ultrasound palpation system (TUPS) [45, 55] and US with a load cell or a loading/unloading device [46, 49, 53]. For PTS, reliability was reported for durometer [44, 64], magnetic resonance elastography [62], TUPS [45, 55], US probe with dynamometer [40] and US with a load cell or a loading/unloading device [46, 53]. For ATS, reliability was reported for shear wave elasticity imaging [33], strain elastography [38] and US [68]. None of the studies that assessed ATT reported on the reliability of their assessment technique.

Within these studies, a coefficient of variance between repeated measurements was found to be less than or equal to 5% in six studies [40, 46, 49, 53, 57, 68] and less than 10% in one study [62]. Excellent intra-class correlation coefficient (ICC) of the test-retest reliability was found in two studies (ICC > 0.8) [33, 37]. Intra-operator reliability was tested but not reported in one study [67]. No mention of reliability was made in the remaining 60% of studies (21/35).

Validity of outcome measures was reported in 11% of studies (4/35). All four studies had cited previous works in demonstrating the validity of their chosen assessment tools for their specified outcome measure(s). Two studies [45, 55] have indicated that the validity of the TUPS had been demonstrated for both PTT and PTS. One study [44] had indicated that the validity of the durometer had been demonstrated for PTS. In relation to the AT, only one study [68] had indicated that the validity of US had been demonstrated for ATS. None of the studies that assessed ATT had reported on the validity of their assessment technique. No mention of validity was reported in the remaining 89% of studies (31/35).

Outcome metrics

For PTS, 18 different outcome metrics were adopted across 19 studies (Table 3). Of these, two or more metrics were utilised by six studies. For ATS, four different outcome metrics were noted across five studies. These include an elastographic colour map [38], shear wave velocity [33, 35], Young’s modulus [41], and a measurement of the slope over the last 20% of tendon deformation from fitting the force-deformation data to a third-order polynomial [68].

Table 3 Plantar tissue stiffness outcome metrics

Assessment techniques

Assessment tools

Plantar tissue thickness

From 20 studies investigating PTT, five different assessment tools were used. 80% of studies (16/20) utilised US-based measures [39,40,41,42,43, 45, 46, 49, 50, 52, 53, 55, 58,59,60,61], while the following instruments were used by one study each: CT [57], MRI [37], optical coherence tomography [36] and spiral X-ray CT [56]. Of US-based studies, 50% (8/16) utilised US alone [39, 43, 45, 50, 52, 59,60,61], 25% utilised TUPS [41, 42, 45, 55], 25% combined use of US with either a load cell or indentation system [46, 49, 53, 58] and one study utilised an US connected with a dynamometer [40]. Chao et al. (2011) [45] was the only study to utilise two different techniques in their assessment: US for the epidermis only and TUPS for total PTT. 63% of studies (10/16) utilised B-mode US [39, 40, 43, 45, 46, 49, 52, 55, 60, 61], 19% utilised M-mode US [42, 45, 49], 13% utilised A-mode US [45, 50] and 19% did not specify the US modality utilised [41, 58, 59]; Chao et al. (2011) [45] and Hsu et al. (2007) [49] used more than one US modality.

Plantar tissue stiffness

From 19 papers assessing PTS, six different assessment tools were used. 47% of studies (9/19) utilised US-based measures [40,41,42, 45, 46, 53, 55, 58, 62], 26% utilised the durometer [44, 51, 52, 59, 64], 11% utilised cutometer [36, 50], and the following instruments were used by one study each: indentor system [63], subject-specific finite element model [34] and spiral X-ray CT [56]. Of US-based studies, 44% (4/9) utilised TUPS [41, 42, 45, 55], 22% combined use of the US with either an indentation system or load cell [46, 58], and one study each utilised: US alone [53], US connected with a dynamometer [40] and magnetic resonance elastography [62]. Within these, 50% utilised B-mode US [40, 46, 53, 55], 25% utilised M-mode US [42, 45], 13% utilised A-mode US [45] and 25% did not specify the US modality utilised [41, 58]; Chao et al. (2011) [45] used more than one US modality.

Achilles tendon thickness and stiffness

From nine studies assessing ATT, two different assessment tools are used. 89% of studies (8/9) utilised US-based measures, with 78% utilised US [33, 35, 38, 48, 65,66,67] and 11% utilising TUPS [41]. The remaining study utilised the MRI [47]. From five studies assessing ATS, all five studies utilised US-based tools albeit using five different assessment techniques. One study each utilised the acoustic radiation force impulse elastography [35], strain elastography [38], shear wave elasticity imaging [33], TUPS [41] and US [68].

Method of measurement

Plantar tissue thickness

PTT was measured as the distance between skin and bone in 70% of studies (14/20) [37, 41, 42, 45, 46, 49, 52, 53, 55,56,57,58,59,60]. A slight variation in measurement was noted in one study, with the authors measuring PTT as the distance between probe and bone instead [40]. Other heterogeneous methods of measuring PTT includes: measurements of the epidermis only [45, 50], the epidermis and upper dermis measured separately [43], the epidermis and dermis combined [39], and the epidermal-dermal junction zone only [36]. The method of measuring PTT was not explicitly stated in one study [61]. PTT values extracted from all 20 studies can be found in Additional file 3.

Achilles tendon thickness

Some uniformity was noted in the method of measurement for ATT across papers. ATT was measured as the anteroposterior diameter across the examined AT portion(s) in 56% of studies (5/9) [33, 35, 38, 47, 48]. However, these measurements were made in the longitudinal plane in two studies [35, 48] and from transverse scans in two other studies [33, 38]. The plane of measurement was not stated in Papanas et al’s (2009) study [47]. Instead of measuring the thickest point of the examined portion(s), Cheing et al. (2013) [41] was the only study to have adopted a different method of measurement. In their study, ATT was measured from the superior surface of the AT to its insertion at the posterior calcaneus. The method of measuring ATT was not explicitly stated in the remaining three studies [65,66,67]. ATT values extracted from all 9 studies can be found in Additional file 4.

Anatomic sites examined

Plantar tissue thickness

Across 20 studies examining PTT, 30% examined the hallux, 60% examined the first metatarsal head (MTH), 45% examined the second MTH, 45% examined the third MTH, 30% examined the fourth MTH, 40% examined the fifth MTH and 60% examined the heel. Robertson et al. (2002) [57] did not report their findings for each MTH individually, instead providing it as a mean and standard deviation across all five MTHs for each cohort. Thomas et al. (2003) [52] had similarly merged their findings for the third to fifth MTHs. None of the studies had examined PTT at the lesser toes.

Plantar tissue stiffness

Across 19 studies examining PTS, 37% examined the hallux, 58% examined the first MTH, 26% examined the second MTH, 32% examined the third MTH, 5% examined the fourth MTH, 26% examined the fifth MTH, 11% examined the medial and lateral midfoot, and 84% examined the heel. 16% of studies had merged their findings for the third to fifth MTHs [44, 51, 52]. One study had compared the microchambers and macrochambers in the heel [46]. One study had compared the plantar skin and fat layer at the heel [34]. None of the studies had examined PTS at the lesser toes.

Achilles tendon thickness and stiffness

Across 10 studies which had investigated either ATT and/or ATS, 20% of studies (2/10) had differentiated their measurements between all three portions of the AT. Both studies [33, 38] concurred in their method of measurement, in that the proximal third portion was measured at the myotendinous junction, the mid-portion was measured 2–6 cm above its insertion at the calcaneus, while the distal third portion was measured at the AT insertion at the calcaneus. Of the remaining studies, 60% [35, 41, 48, 66,67,68] examined only one out of three portions of the AT, while 20% [47, 65] had not specified the portion(s) they had examined.

Key findings

The main findings for PTT, PTS, ATT and ATS outcomes are tabulated in Table 4.

Table 4 Main findings

Plantar tissue thickness and stiffness

Across 20 studies examining PTT, no significant differences were found between people with and without diabetes across all examined anatomical site(s) in 55% of studies (11/20) [36, 40,41,42, 46, 49, 53, 55,56,57, 59] (Additional file 5). When compared with otherwise healthy controls, 10% of studies (2/20) reported significantly reduced PTT [39, 58] and 5% (1/20) reported significantly increased PTT in their cohort with diabetes [61]. Extensive variations were noted in the remaining 30% of studies (6/20), with plantar tissues observed to be significantly thicker, thinner and not significantly different between diabetes and healthy control groups. These findings further varied across anatomical sites examined [37, 43, 52, 60] or sub-groups [43, 45, 50] compared (Additional file 5).

Across 19 studies examining PTS, a significant increase in PTS for people with diabetes was observed in 47% of studies (9/19). Of these, 26% of studies (5/19) noted significantly increased PTS across all examined site(s) in cohorts with diabetes when compared to their healthy controls [40, 42, 45, 55, 58] and 21% of studies (4/19) shared this trend of significant increase across all bar one of their examined sites [36, 41, 44, 51] (Additional file 5). One study (5%) noted an increase in PTS across all examined sites, however it is uncertain if this reached significance as inferential statistics was not conducted for PTS differences between groups [56]. No significant differences in all examined sites between groups were observed in 21% of studies (4/19) [46, 53, 62, 64]. By contrast, none of the studies concluded that a reduction in PTS was found for their cohorts with diabetes. The remaining 26% of studies (5/19) reported variations in their findings depending on the anatomical region examined [34, 59], outcome metric utilised [50, 63] or sub-groups compared [52] (Additional file 5).

Achilles tendon thickness and stiffness

Across nine studies that analysed ATT, 44% (4/9) found a significant increase across all examined portion(s) in people with diabetes when compared to healthy controls [33, 35, 41, 66] (Additional file 6). No significant differences in ATT between groups were observed in 33% of studies (3/9) [38, 47, 67]. One (11%) study found reduced ATT in people with diabetes, however it is not known if this difference was significant as inferential statistics was not conducted for ATT measurements [65]. Sex variations in findings were noted in 22% of studies (2/9) [47, 48]. Both studies reported significantly greater ATT in women with Type 2 diabetes when compared to women without diabetes, but no significant differences were found between men with Type 2 diabetes and men without diabetes.

Across five studies that measured ATS, 60% (3/5) found no significant differences across all examined portion(s) between people with and without diabetes [35, 38, 41]. One study (20%) found a significant reduction in ATS for their cohort with diabetes [33] and the remaining study’s (20%) findings differed depending on the outcome metric utilised [68] (Additional file 6).

Sub-group analysis

Participants with diabetes-related peripheral neuropathy

Seven studies investigating PTT [39, 41, 42, 45, 52, 55, 58], nine studies investigating PTS [41, 42, 44, 45, 52, 55, 58, 62, 64], six studies investigating ATT [33, 35, 41, 47, 66, 67] and three studies investigating ATS [33, 35, 41] analysed their findings separately for participants with DPN. More than half of studies found no significant differences in PTT between people with DPN and healthy controls [41, 42, 52, 55] (57%, 4/7 studies) and significantly increased PTS in people with DPN compared to healthy controls [42, 45, 55, 58, 64] (56%, 5/9 studies). A further 22% studies [41, 44] (2/9) found significantly increased PTS across all bar one site for participants with DPN. The majority of studies found significantly increased ATT [33, 35, 41, 66, 67] (83%, 5/6 studies) and significantly reduced ATS (67%, 2/3 studies) in people with DPN when compared to healthy controls [33, 35]. Of these studies, the confounding effect of age could not be eliminated for Zheng et al. (2000) [58] as they had compared elderly DPN with young healthy controls.

Participants with an active or a history of diabetes-related foot ulcerations

Eight studies investigating PTT [43, 45, 52, 53, 56, 57, 59, 60], six studies investigating PTS [45, 52, 53, 56, 59, 63], three studies investigating ATT [38, 66, 67] and one study investigating ATS [38] analysed their findings separately for people with either an active or a history of DFUs. Half of studies investigating PTT (4/8) found no significant differences between groups [53, 56, 57, 59]. No clear pattern was identified for PTS (Additional file 5). All studies investigating ATT [38, 66, 67] (3/3) found ATT to be significantly increased in their cohort with DFU. The only study investigating ATS found stiffness to be significantly lower in people with active DFUs when compared with people with Type 2 diabetes and healthy controls at the distal (insertional) and mid-portion only; no significant differences were found between groups at the proximal segment (myotendinous junction) [38].

Brink (1995) [59] and Thomas et al. (2003) [52] were the only two studies to directly compare their findings for either active or healed DFU sites with non-ulcerated sites. Both studies found PTS at DFU sites to be increased when compared to non-ulcerated sites. Hsu et al. (2000) [53] limited their cohort to participants with active forefoot DFUs (Wagner grade 2 or 3) whilst investigating PTS at the heel.

Comparing findings across diabetes-related foot complications

In studies which compared findings across subgroups with different diabetes-related foot complications, no significant differences in PTT were found between people with diabetes and those with DPN [39, 41], as well as between people with and without DFU [53]. No significant differences in ATT was found between people with diabetes and those with DPN [33, 35, 47, 66], while ATT was found to be significantly increased in participants with DFU compared to those without DFU [38, 66, 67].

Anatomical variations

Plantar soft tissues

Changes to plantar tissue sub-structures are seldom reported. Chao et al. (2012) [43] measured the differences in tissue thickness between the epidermis and upper dermis, while Chao et al. (2011) [45] measured the differences in thickness between the epidermis and total plantar tissues. Regional variations in PTT were observed in 30% of studies (6/20), with findings which further varied depending on the anatomical sites [37, 43, 52, 60] or sub-groups [43, 45, 50] compared (Additional file 5); no clear pattern emerged from this.

Regional variations in PTS were observed in only one out of all other examined sites in 26% of studies (5/19) [36, 41, 44, 51, 52]. More extensive regional variations in PTS were noted in only one study [59] (5%) with contradictory findings (Additional file 5). Kwak et al. (2020) [34] reported differences between plantar fat pad and skin stiffness, while Hsu et al. (2009) [46] reported differences in micro- and macrochamber stiffness in the heel pads.

Achilles tendon

Only two studies distinguished their findings between the three segments of the AT (myotendinous junction, mid-portion and insertion) [33, 38], both studies utilised US. While they shared the observation that ATT findings for each individual segment had not differed from each other [33, 38], Evranos et al. (2015) [38] noted that ATS differed in the proximal segment (myotendinous junction) when compared with the mid- and distal (insertional) segments (Additional file 6). Additionally, only two studies analysed the US-derived echotexture of the AT [33, 65]. Altered patterns were found in people with diabetes in the form of hypoechogenicity, loss of fibrillar pattern, calcification at the tendon insertion at the calcaneus and/or retrocalcaneal bursitis.


Principal findings

This systematic review investigated the evidence for differences in plantar soft tissue and AT thickness and stiffness in people with and without diabetes. The general consensus among studies was that diabetes is associated with a significant increase in PTS, however the differences in PTT is not significant. Studies also found that diabetes is associated with a significant increase in ATT, however the differences in ATS is not significant.

Methodological considerations

Extensive methodological heterogeneities and deficiencies was a key finding of this systematic review. Sample sizes were seldom justified (3%, 1/35). Additionally, reporting was generally inadequate across the domains of study designs and the reliability and validity of outcome measures. Case definition for participants with diabetes and subgroups formed on the presence and history of DFU or DPN were often absent or inadequately defined. Furthermore, the risk of selection bias cannot be eliminated in the majority of studies as only 6% of studies adopted a consecutive sampling method for recruiting people with diabetes; the remaining 94% of studies (33/35) made no mention of their sampling strategy for their cohorts with diabetes.

No gold standard assessment techniques have been established for tissue thickness and stiffness assessments and this was reflected in the diverse approaches reported in this review. Studies that employed novel biomedical technologies and tissue engineering outcomes are additionally not easily reproduced and are not well understood in clinical settings. Ultrasound-based techniques were favoured – utilised by 80% of studies (16/20) investigating PTT, 47% of studies (9/19) investigating PTS, 89% of studies (8/9) investigating ATT, and 100% of studies (5/5) investigating ATS – but standardisation in its usage is lacking. Ultrasound-based techniques are also known to be highly dependent on the knowledge, experience and skill of the operator [69]. Therefore, the extent to which outcomes have been reliably measured is important. However, no mention of reliability was made in 60% of studies (21/35).

Studies further differed in their measurement techniques. Using PTT for example, while the majority of studies (70%, 14/20) measured PTT as the distance between skin and bone, overall six different methods of measurements were observed. Combined with the use of different assessment techniques and examination of different anatomical sites, these wide-ranging methodological heterogeneities made it difficult to compare and synthesise results across studies. The lack of standardisation also renders derivation of normal and diagnostic cut-off values extremely challenging and hampers routine clinical utility for at-risk screening, detection and longitudinal monitoring.

Role of plantar soft tissues thickness and stiffness in DFU

On the plantar aspect of the foot, areas at high risk of ulceration are the apices of the toes, metatarsal heads, medial aspect of the midfoot and the heel [4]. This systematic review observed that evidence for the differences in PTS is more consistent across included studies than PTT (Additional file 5). However, regional variations in either PTT or PTS appear modest. This implies that other risk factors such as tissue load, in the presence of structural tissue changes, may be more important for the development of DFU rather than either factor alone. These findings reinforce the multi-factorial nature of plantar DFU pathogenesis [5, 6] and the need for further mechanistic and outcome focused research.

The lifetime incidence of DFUs is estimated to be up to 35% [6]. DFU recurrence rates are also high, with the pooled global recurrence rates estimated in a meta-analysis to be 22.1% per person-year (95% CI, 19.0–25.2%) [21]. However, the extent to which plantar soft tissue changes contribute to either the development of primary ulcerations or its recurrence is little understood. No firm conclusions can be drawn from this review, as only 6% of studies (2/35) directly compared either active or healed DFU sites with never-ulcerated sites. Additionally, none of the included studies measured differences in PTT or PTS at the apices of the toes. Combining the paucity of studies primarily investigating these associations with the methodological shortfalls identified in existing studies, the clinical significance of tissue thickness or stiffness changes in its role in contributing towards plantar DFUs remains unclear.

Role of Achilles tendon thickness and stiffness in DFU

Achilles tendon changes in diabetes are recognised to potentially alter ankle biomechanics [16], increase forefoot plantar pressures and contribute to tissue breakdown [70]. This systematic review identified that people with diabetes, particularly those with DPN and DFU, may have a thicker AT but reduced AT stiffness. The International Working Group on the Diabetic Foot (IWGDF) guidelines [71] recommend AT lengthening procedures to be considered as a potential management option for the prevention of DFU recurrence. It is not clear what the implications of these findings are for such procedures. The authors of this systematic review are unaware of studies that have specifically investigated the association of either ATT or ATS with AT lengthening procedures and this merits further investigation.

Thickening in tendons are often regarded as pathological clinically [17, 72]. While the site of localised thickening could be important, this review and the evidence synthesised does not elucidate. It is further uncertain if a thicker or thinner AT, stiffer or less stiff AT, presenting simply by virtue of its different thickness or stiffness when compared to an otherwise healthy cohort, can therefore be viewed as pathological in diabetes. To the best of the authors’ knowledge, the normative values of ATT or ATS have not been established in a cohort of people with diabetes, such that even in the absence of symptomology, said AT changes should therefore be regarded as tendinopathic.

Asymptomatic AT pathologies are common in athletic and general populations [73,74,75,76]. While AT structural changes do not always trigger tendon pain [77], this could arguably be more prevalent in people with diabetes due to masking from DPN. However, the lack of symptoms may not negate the potential for occult AT thickness or stiffness changes to persist in its alterations to gait. To this end, this systematic review contributes to this research gap by providing indicative ATT values from included studies (Additional file 4). The extensive heterogeneity in outcome metrics prevented similar consolidations in findings for ATS. Further work is required and advances in technology may afford greater insights into the ATT and ATS changes in diabetes.

Potential confounders

It is further unclear to what extent baseline factors such as age, sex, BMI, duration of diabetes and glycaemic control are associated with soft tissue changes in diabetes. In this systematic review, the differences between groups with diabetes and control groups in age, sex and BMI were statistically not significant in 40% of studies which appears to reduce the potential for confounding. However, studies reviewed have documented poor correlations between age with PTT [37, 40], PTS [40] and ATT [33] differences; BMI with PTT and PTS differences [40]; duration of diabetes with PTT [40], PTS [40] and ATT [33] differences; as well as HbA1c levels with PTT [39, 40], PTS [40] and ATT [33] differences between people with and without diabetes. Strong correlations have however been found between triglyceride levels and PTS differences in the heel for people with diabetes [40]. Nonetheless, it was difficult to tease out whether soft tissue alterations were due to the adequacy of glycaemic control, chronicity of hyperglycaemia, hypertriglyceridemia, severity of DPN or other potential confounders in demographics. This requires careful attention in future studies.

Strengths and limitations

This systematic review has several strengths. The review included all studies published to date on the topic, including a body of knowledge from the biomedical technology field where assessment techniques were utilised in cohorts of people with diabetes and associated risk factors for DFU. Extensive search strategies were employed with detailed, careful and critical assessment to identify risk of bias. The review is, however, limited by the methodological deficiencies of included studies. The critical appraisal tool by McMaster University [24] has also not been validated and the threshold for distinguishing between grades of methodological quality have not been established. Substantial methodological heterogeneities prevented the conduct of meta-analysis which further limits the review. Additionally, two papers with similar cohorts may have contributed to the observed heterogeneity. However, since no pooled analysis was undertaken, the effect on the precision of the estimated outcome is unclear.


This systematic review found some preliminary evidence supporting differences in soft tissue properties in the feet of people with and without diabetes. However, uncertainties remain largely due to methodological heterogeneities and deficiencies. Tissue thickness and stiffness are putative risk factors for DFU and may be a viable treatment target. High-quality studies using standardised and validated assessment techniques in well-defined populations are required to advance our understanding and to determine more fully the role of soft tissue thickness or stiffness changes in the pathogenesis of DFU. Should soft tissue compromise be indicative of imminent tissue breakdown in the diabetic foot, this has the potential to aid clinical triage and inform the timely adoption of targeted preventive measures.

Availability of data and materials

All data generated or analysed during this study are included in this published article (and its supplementary information files).



Advanced glycosylation end-products


Achilles tendon


Achilles tendon stiffness


Achilles tendon thickness


Body mass index


Computed tomography


Diabetes-related foot ulceration


Diabetes-related peripheral neuropathy


Intra-class correlation coefficient


Meta-analyses Of Observational Studies in Epidemiology


Magnetic resonance imaging


Metatarsal head


Preferred Reporting Items for Systematic Reviews and Meta-Analyses


Plantar tissue stiffness


Plantar tissue thickness


Tissue ultrasound palpation system




  1. 1.

    Vadiveloo T, Jeffcoate W, Donnan PT, Colhoun HC, McGurnaghan S, Wild S, et al. Amputation-free survival in 17,353 people at high risk for foot ulceration in diabetes: a national observational study. Diabetologia. 2018;61(12):2590–7.

    Article  PubMed  PubMed Central  Google Scholar 

  2. 2.

    National Institute for Health and Care Excellence (NICE). Diabetic foot problems: prevention and management 2015. Available from:

    Google Scholar 

  3. 3.

    World Union of Wound Healing Societies (WUWHS), Florence Congress, Position Document. Local management of diabetic foot ulcers. Wounds International; 2016. Available from: Accessed 6 May 2020.

  4. 4.

    Schaper NCC, van Netten JJ, Apelqvist J, Bus SAA, Hinchliffe RJJ, Lipsky BAA. Practical guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36(Suppl 1):e3266.

  5. 5.

    Boulton AJM. The pathway to foot ulceration in diabetes. Med Clin North Am. 2013;97(5):775–90.

    Article  PubMed  Google Scholar 

  6. 6.

    Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017;376(24):2367–75.

    Article  PubMed  Google Scholar 

  7. 7.

    Van Putte L, De Schrijver S, Moortgat P. The effects of advanced glycation end products (AGEs) on dermal wound healing and scar formation: a systematic review. Scars Burn Heal. 2016;2:1–14.

  8. 8.

    Wang Y, Lee K, Ledoux W. Histomorphological evaluation of diabetic and non-diabetic plantar soft tissue. Foot Ankle Int. 2011;32(8):802–10.

    Article  PubMed  PubMed Central  Google Scholar 

  9. 9.

    Guney A, Vatansever F, Karaman I, Kafadar IH, Oner M, Turk CY. Biomechanical properties of Achilles tendon in diabetic vs non-diabetic patients. Exp Clin Endocrinol Diabetes. 2015;123(7):428–32.

    CAS  Article  PubMed  Google Scholar 

  10. 10.

    Grant WP, Sullivan R, Sonenshine DE, Adam M, Slusser JH, Carson KA, et al. Electron microscopic investigation of the effects of diabetes mellitus on the Achilles tendon. J Foot Ankle Surg. 1997;36(4):272–8.

    CAS  Article  PubMed  Google Scholar 

  11. 11.

    Nawale RB, Mourya VK, Bhise SB. Non-enzymatic glycation of proteins: a cause for complications in diabetes. Indian J Biochem Biophys. 2006;43(6):337–44.

    CAS  PubMed  Google Scholar 

  12. 12.

    Singh VP, Bali A, Singh N, Jaggi AS. Advanced glycation end products and diabetic complications. Korean J Physiol Pharmacol. 2014;18(1):1–14.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  13. 13.

    Ahmed N, Thornalley PJ. Advanced glycation endproducts: what is their relevance to diabetic complications? Diabetes Obes Metab. 2007;9(3):233–45.

  14. 14.

    De Jonge S, Rozenberg R, Vieyra B, Stam HJ, Aanstoot HJ, Weinans H, et al. Achilles tendons in people with type 2 diabetes show mildly compromised structure: an ultrasound tissue characterisation study. Br J Sports Med. 2015;49(15):995–9.

    Article  PubMed  Google Scholar 

  15. 15.

    Cheung JTM, Zhang M, Leung AKL, Fan YB. Three-dimensional finite element analysis of the foot during standing – a material sensitivity study. J Biomech. 2005;38(5):1045–54.

  16. 16.

    Rao SR, Saltzman CL, Wilken J, Yak HJ. Increased passive ankle stiffness and reduced dorsiflexion range of motion in individuals with diabetes mellitus. Foot Ankle Int. 2006;27(8):617–22.

    Article  PubMed  PubMed Central  Google Scholar 

  17. 17.

    Obst SJ, Heales LJ, Schrader BL, Davis SA, Dodd KA, Holzberger CJ, et al. Are the mechanical or material properties of the Achilles and Patellar tendons altered in Tendinopathy? A systematic review with meta-analysis. Sport Med. 2018;48(9):2179–98.

    Article  Google Scholar 

  18. 18.

    Maganaris CN, Narici MV, Maffulli N. Biomechanics of the Achilles tendon. Disabil Rehabil. 2008;30(20–22):1542–7.

    Article  PubMed  Google Scholar 

  19. 19.

    Obst SJ, Barrett RS, Newsham-West R. Immediate effect of exercise on Achilles tendon properties: systematic review. Med Sci Sports Exerc. 2013;45(8):1534–44.

    Article  PubMed  Google Scholar 

  20. 20.

    Maffulli N, Sharma P, Luscombe KL. Achilles tendinopathy: Aetiology and management. J R Soc Med. 2004;97(10):472–6.

    Article  PubMed  PubMed Central  Google Scholar 

  21. 21.

    Fu XL, Ding H, Miao WW, Mao CX, Zhan MQ, Chen HL. Global recurrence rates in diabetic foot ulcers: a systematic review and meta-analysis. Diabetes Metab Res Rev. 2019;35(6):e3160.

    Article  PubMed  Google Scholar 

  22. 22.

    Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. J Am Med Assoc. 2000;283(15):2008–12.

    CAS  Article  Google Scholar 

  23. 23.

    Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.

  24. 24.

    Law M, Stewart D, Pollock N, Letts L, Bosch J, Westmorland M. Critical review form – Quantitative studies. 1998. Available from: Accessed 16 Apr 2020.

  25. 25.

    Law M, Stewart D, Pollock N, Letts L, Bosch J, Westmorland M. Guidelines for critical review form – Quantitative studies. 1998. Available from: Accessed 16 Apr 2020.

  26. 26.

    Abate M, Schiavone C, Di Carlo L, Salini V. Achilles tendon and plantar fascia in recently diagnosed type II diabetes: role of body mass index. Clin Rheumatol. 2012;31(7):1109–13.

    Article  PubMed  Google Scholar 

  27. 27.

    Intziegianni K, Cassel M, Hain G, Mayer F. Gender differences of Achilles tendon cross-sectional area during loading. Sport Med Int Open. 2017;1(4):E135–40.

  28. 28.

    Taş S. Effect of gender on mechanical properties of the plantar fascia and heel fat pad. Foot Ankle Spec. 2018;11(5):403–9.

    Article  PubMed  Google Scholar 

  29. 29.

    Turan A, Teber MA, Yakut ZI, Unlu HA, Hekimoglu B. Sonoelastographic assessment of the age-related changes of the Achilles tendon. Med Ultrason. 2015;17(1):58–61.

    Article  PubMed  Google Scholar 

  30. 30.

    Ochala J, Valour D, Pousson M, Lambertz D, Van Hoecke J. Gender differences in human muscle and joint mechanical properties during plantar flexion in old age. J Gerontol – Ser A. 2004;59(5):B441–8.

  31. 31.

    Kubo K, Kanehisa H, Fukunaga T. Gender differences in the viscoelastic properties of tendon structures. Eur J Appl Physiol. 2003;88(6):520–6.

    Article  PubMed  Google Scholar 

  32. 32.

    Kwan RLC, Zheng YP, Cheing GLY. The effect of aging on the biomechanical properties of plantar soft tissues. Clin Biomech. 2010;25(6):601–5. Accessed 03 Apr 2010.

  33. 33.

    Harish SC, Dixit R, Singh S, Garg S. Sonoelastographic evaluation of the Achilles tendon in patients with type 2 diabetes mellitus. Ultrasound Med Biol. 2020;46(11):2989–97.

  34. 34.

    Kwak Y, Kim J, Lee KM, Koo S. Increase of stiffness in plantar fat tissue in diabetic patients. J Biomech. 2020;107:109857.

    Article  PubMed  Google Scholar 

  35. 35.

    İyidir ÖT, Rahatlı FK, Bozkuş Y, Ramazanova L, Turnaoğlu H, Nar A, et al. Acoustic radiation force impulse elastography and ultrasonographic findings of Achilles tendon in patients with and without diabetic peripheral neuropathy: a cross-sectional study. Exp Clin Endocrinol Diabetes. 2019;129(2):99–103.

  36. 36.

    Lechner A, Akdeniz M, Tomova-Simitchieva T, Bobbert T, Moga A, Lachmann N, et al. Comparing skin characteristics and molecular markers of xerotic foot skin between diabetic and non-diabetic subjects: an exploratory study. J Tissue Viability. 2019;28(4):200–9.

    Article  PubMed  Google Scholar 

  37. 37.

    Oh S, Kim J, Choi J, Jeong W, Chang H, Lee S. Comparison of pedal soft tissue thickness between those with and without diabetes. J Foot Ankle Surg. 2018;57(5):860–4.

    Article  PubMed  Google Scholar 

  38. 38.

    Evranos B, Idilman I, Ipek A, Polat SB, Cakir B, Ersoy R. Real-time sonoelastography and ultrasound evaluation of the Achilles tendon in patients with diabetes with or without foot ulcers: a cross sectional study. J Diabetes Complicat. 2015;29(8):1124–9.

    Article  Google Scholar 

  39. 39.

    Kumar CGS, Rajagopal KV, Hande HM, Maiya AG, Mayya SS. Intrinsic foot muscle and plantar tissue changes in type 2 diabetes mellitus. J Diabetes. 2015;7(6):850–7.

    Article  PubMed  Google Scholar 

  40. 40.

    Chatzistergos PE, Naemi R, Sundar L, Ramachandran A, Chockalingam N. The relationship between the mechanical properties of heel-pad and common clinical measures associated with foot ulcers in patients with diabetes. J Diabetes Complicat. 2014;28(4):488–93.

    Article  Google Scholar 

  41. 41.

    Cheing GLY, Chau RMW, Kwan RLC, Choi CH, Zheng YP. Do the biomechanical properties of the ankle-foot complex influence postural control for people with type 2 diabetes? Clin Biomech. 2013;28(1):88–92.

    Article  Google Scholar 

  42. 42.

    Jan YK, Lung CW, Cuaderes E, Rong D, Boyce K. Effect of viscoelastic properties of plantar soft tissues on plantar pressures at the first metatarsal head in diabetics with peripheral neuropathy. Physiol Meas. 2013;34(1):53–66.

    Article  PubMed  Google Scholar 

  43. 43.

    Chao CYL, Zheng YP, Cheing GLY. The association between skin blood flow and edema on epidermal thickness in the diabetic foot. Diabetes Technol Ther. 2012;14(7):602–9.

    Article  PubMed  PubMed Central  Google Scholar 

  44. 44.

    Periyasamy R, Anand S, Ammini AC. Investigation of shore meter in assessing foot sole hardness in patients with diabetes mellitus – a pilot study. Int J Diabetes Dev Ctries. 2012;32(3):169–75.

  45. 45.

    Chao CYL, Zheng YP, Cheing GLY. Epidermal thickness and biomechanical properties of plantar tissues in diabetic foot. Ultrasound Med Biol. 2011;37(7):1029–38.

    Article  PubMed  Google Scholar 

  46. 46.

    Hsu CC, Tsai WC, Hsiao TY, Tseng FY, Shau YW, Wang CL, et al. Diabetic effects on microchambers and macrochambers tissue properties in human heel pads. Clin Biomech. 2009;24(8):682–6.

    Article  Google Scholar 

  47. 47.

    Papanas N, Courcoutsakis N, Papatheodorou K, Daskalogiannakis C, Maltezos E, Prassopoulos P. Achilles tendon volume in type 2 diabetic patients with or without peripheral neurooathy: MRI study. Exp Clin Endocrinol Diabetes. 2009;117(10):645–8.

    CAS  Article  PubMed  Google Scholar 

  48. 48.

    Akturk M, Ozdemir A, Maral I, Yetkin I, Arslan M. Evaluation of achilles tendon thickening in type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes. 2007;115(2):92–6.

    CAS  Article  PubMed  Google Scholar 

  49. 49.

    Hsu CC, Tsai WC, Shau YW, Lee KL, Hu CF. Altered energy dissipation ratio of the plantar soft tissues under the metatarsal heads in patients with type 2 diabetes mellitus: a pilot study. Clin Biomech. 2007;22(1):67–73.

    Article  Google Scholar 

  50. 50.

    Hashmi F, Malone-Lee J, Hounsell E. Plantar skin in type II diabetes: an investigation of protein glycation and biomechanical properties of plantar epidermis. Eur J Dermatol. 2006;16(1):23–32 Available from:

    CAS  PubMed  Google Scholar 

  51. 51.

    Puri M, Patil IKM, Balasubramanian IV, Narayanamurthy VB. Texture analysis of foot sole soft tissue images in diabetic neuropathy using wavelet transform. Med Biol Eng Comput. 2005;43(6):756–63.

    CAS  Article  PubMed  Google Scholar 

  52. 52.

    Thomas VJ, Patil KM, Radhakrishnan S, Narayanamurthy VB, Parivalavan R. The role of skin hardness, thickness, and sensory loss on standing foot power in the development of plantar ulcers in patients with diabetes mellitus – a preliminary study. Int J Low Extrem Wounds. 2003;2(3):132–9.

  53. 53.

    Hsu TC, Wang CL, Shau YW, Tang FT, Li KL, Chen CY. Altered heel-pad mechanical properties in patients with type 2 diabetes mellitus. Diabet Med. 2000;17(12):854–9.

    CAS  Article  PubMed  Google Scholar 

  54. 54., Centers for Disease Control and Prevention,, Centers for Disease Control and Prevention. Type 2 Diabetes. 2019. Available from: Accessed 28 Oct 2020.

  55. 55.

    Sun JH, Cheng BK, Zheng YP, Huang YP, Leung JY, Cheing GL. Changes in the thickness and stiffness of plantar soft tissues in people with diabetic peripheral neuropathy. Arch Phys Med Rehabil. 2011;92(9):1484–9.

    Article  PubMed  Google Scholar 

  56. 56.

    Mueller MJ, Hastings M, Commean PK, Smith KE, Pilgram TK, Robertson D, et al. Forefoot structural predictors of plantar pressures during walking in people with diabetes and peripheral neuropathy. J Biomech. 2003;36(7):1009–17.

    Article  PubMed  Google Scholar 

  57. 57.

    Robertson DD, Mueller MJ, Smith KE, Commean PK, Pilgrim T. Structural changes in the forefoot of individuals with diabetes and a prior plantar ulcer. J Bone Jt Surg. 2002;84(8):1395–404.

  58. 58.

    Zheng Y, Choi Y, Wong K, Chan S, Mak A. Biomechanical assessment of plantar foot tissue in diabetic patients using an ultrasound indentation system. Ultrasound Med Biol. 2000;26(3):451–6.

    CAS  Article  PubMed  Google Scholar 

  59. 59.

    Brink T. Induration of the diabetic foot pad: another risk factor for recurrent neuropathic plantar ulcers. Biomed Tech Band. 1995;40(7–8):205–9.

    CAS  Article  Google Scholar 

  60. 60.

    Gooding G, Stess R, Graf P, Moss K, Louie K, Grunfeld C. Sonography of the sole of the foot: Evidence for loss of foot pad thickness in diabetes and its relationship to ulceration of the foot. Investig Radiol. 1986;21(1):45–8.

  61. 61.

    Gooding GAW, Stress RMD, Graf PMD, Grunfeld C. Heel pad thickness: determination by high-resolution ultrasonography. J Ultrasound Med. 1985;4(4):173–4.

  62. 62.

    Cheung Y, Doyley M, Miller T, Kennedy F, Lynch FJ, Wrobel J, et al. Magnetic resonance elastography of the plantar fat pads: preliminary study in diabetic patients and asymptomatic volunteers. J Comput Assist Tomogr. 2006;30(2):321–6.

    Article  PubMed  Google Scholar 

  63. 63.

    Klaesner JW, Hastings MK, Zou D, Lewis C, Mueller MJ. Plantar tissue stiffness in patients with diabetes mellitus and peripheral neuropathy. Arch Phys Med Rehabil. 2002;83(12):1796–801.

    Article  PubMed  Google Scholar 

  64. 64.

    Piaggesi A, Romanelli M, Schipani E, Campi F, Magliaro A, Baccetti F, et al. Hardness of plantar skin in diabetic neuropathic feet. J Diabetes Complicat. 1999;13(3):129–34.

    CAS  Article  Google Scholar 

  65. 65.

    Batista F, Nery C, Pinzur M, Monteiro AC, de Souza EF, Felippe FHZ, et al. Achilles tendinopathy in diabetes mellitus. Foot Ankle Int. 2008;29(5):498–501.

  66. 66.

    D’Ambrogi E, Giacomozzi C, Macellari V, Uccioli L. Abnormal foot function in diabetic patients: the altered onset of windlass mechanism. Diabet Med. 2005;22(12):1713–9.

    Article  PubMed  Google Scholar 

  67. 67.

    Giacomozzi C, D’Ambrogi E, Uccioli L, MacEllari V. Does the thickening of Achilles tendon and plantar fascia contribute to the alteration of diabetic foot loading? Clin Biomech. 2005;20(5):532–9.

    CAS  Article  Google Scholar 

  68. 68.

    Couppé C, Brüggebusch Svensson R, Kongsgaard M, Kovanen V, Grosset J-F, Snorgaard O, et al. Human Achilles tendon glycation and function in diabetes. J Appl Physiol. 2016;120(2):130–7.

    CAS  Article  PubMed  Google Scholar 

  69. 69.

    Portaceli-Oñatea E, Puglisib F, Martínez-Payá J, del Baño-Aledoa M, Ríos-Díaza J. Quality of reliability studies for ultrasound evaluation of Achilles tendon: a systematic review. J Invasive Tech Phys Ther. 2016;1(1):51–9.

    Google Scholar 

  70. 70.

    Fernando ME, Crowther RG, Lazzarini PA, Sangla KS, Wearing S, Buttner P, et al. Plantar pressures are higher in cases with diabetic foot ulcers compared to controls despite a longer stance phase duration. BMC Endocr Disord. 2016;16(1):e99050.

  71. 71.

    Bus SA, Lavery LA, Monteiro-Soares M, Rasmussen A, Raspovic A, Sacco ICN, et al. Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36(S1):1–18.

  72. 72.

    Kader D, Saxena A, Movin T, Maffulli N. Achilles tendinopathy: Some aspects of basic science and clinical management. Br J Sports Med. 2002;36:239–49.

  73. 73.

    Docking SI, Cook J. How do tendons adapt? Going beyond tissue responses to understand positive adaptation and pathology development: A narrative review. J Musculoskelet Neuronal Interact. 2019(3):300–10.

  74. 74.

    Fredberg U, Bolvig L. Significance of ultrasonographically detected asymptomatic tendinosis in the patellar and Achilles tendons of elite soccer players: a longitudinal study. Am J Sports Med. 2002;30(4):488–91.

    Article  PubMed  Google Scholar 

  75. 75.

    Hirschmüller A, Frey V, Konstantinidis L, Baur H, Dickhuth HH, Südkamp NP, et al. Prognostic value of achilles tendon doppler sonography in asymptomatic runners. Med Sci Sports Exerc. 2012;44(2):199–205.

    Article  PubMed  Google Scholar 

  76. 76.

    Noback PC, Freibott CE, Tantigate D, Jang E, Greisberg JK, Wong T, et al. Prevalence of asymptomatic Achilles Tendinosis. Foot Ankle Int. 2018;39(10):1205–9.

    Article  PubMed  Google Scholar 

  77. 77.

    Docking SI, Ooi CC, Connell D. Tendinopathy: is imaging telling us the entire story? J Orthop Sports Phys Ther. 2015;45(11):842–52.

    Article  PubMed  Google Scholar 

Download references


B.K. would like to thank The Carnegie Trust for the Universities of Scotland for funding this work.

Additional declarations

Poster presentation at the Diabetic Foot Study Group (DFSG) of the European Association for the Study of Diabetes (EASD) 2020 virtual conference, 18–19 September 2020; awarded 1st prize.


B.K. is a PhD student in podiatry in the School of Health and Life Sciences at Glasgow Caledonian University. She is a recipient of a PhD scholarship funded by The Carnegie Trust for the Universities of Scotland. The funding body played no role in the design or conduct of the study, preparation of the manuscript or the decision to submit this work for publication.

Author information




All authors made substantial contributions to the conception and design of this work, analysis and interpretation of data. B.K. drafted the manuscript, all authors revised it critically for important intellectual content. All authors approved the submitted version. All authors agree to both be personally accountable for the author’s own contributions and to ensure that questions related to the accuracy or integrity of any part of the work, even ones in which the author was not personally involved, are appropriately investigated, resolved, and the resolution documented in the literature.

Corresponding author

Correspondence to Benedictine Yen Chen Khor.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

Database search strategy.

Additional file 2.

Reasons for article exclusion.

Additional file 3.

Plantar tissue thickness values.

Additional file 4.

Achilles tendon thickness values.

Additional file 5.

Directionality of findings for plantar soft tissues.

Additional file 6.

Directionality of findings for Achilles tendon.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Khor, B.Y.C., Woodburn, J., Newcombe, L. et al. Plantar soft tissues and Achilles tendon thickness and stiffness in people with diabetes: a systematic review. J Foot Ankle Res 14, 35 (2021).

Download citation


  • Achilles tendon
  • Diabetic foot
  • Diabetic foot ulcer
  • Diabetes related foot ulcer
  • Plantar soft tissues
  • Soft tissue properties
  • Tissue stiffness
  • Tissue thickness